Target intelligence / Profile preview

Streptococcus pneumoniae conserved surface protein epitopes (Pneumococcal surface protein epitopes)

Target
Pneumococcal surface protein epitopes
Molecular classification
Bacterial surface protein, Virulence factor, Antigen, Adhesin, Choline-binding protein
01

Overview

Streptococcus pneumoniae conserved surface protein epitopes are highly preserved antigenic regions found across the diverse serotypes of the S. pneumoniae bacterium. These epitopes are primarily located on essential virulence factors such as Pneumococcal surface protein A (PspA), Pneumococcal surface protein C (PspC), and Pneumococcal surface adhesin A (PsaA) (Ganaie et al., 2023). Their biological functions include facilitating bacterial attachment to host cells, inhibiting complement-mediated opsonization, and managing ion transport necessary for survival (Brooks & Mias, 2018). Because these proteins are conserved across nearly all pneumococcal strains, they serve as critical targets for next-generation, serotype-independent vaccines and monoclonal antibody therapies. In the context of disease, these targets are central to the pathogenesis of pneumonia, meningitis, and sepsis by allowing the bacteria to colonize the nasopharynx and disseminate into the bloodstream (Kadioglu et al., 2008). Therapeutic strategies focusing on these epitopes aim to elicit opsonophagocytic antibodies and neutralize the toxic effects of proteins like Pneumolysin. This approach addresses the limitations of current polysaccharide-based vaccines, which are susceptible to serotype replacement and provide narrower coverage (Astellas Pharma, 2021).

Other names
Conserved pneumococcal antigensStreptococcus pneumoniae surface proteinsSerotype-independent pneumococcal antigensPneumococcal protein-based vaccine targetsPspA/PspC/PsaA epitopes
02

Mechanism of action

Induction of opsonophagocytic antibodies, neutralization of virulence factors, and inhibition of bacterial adhesion to host epithelial cells.

03

Biological functions

Bacterial adhesionImmune evasionComplement inhibitionIon transportToxin activityCell wall metabolism
04

Disease associations

InfectionPneumoniaMeningitisBacteremiaOtitis mediaSinusitis
05

Safety considerations

ReactogenicityPotential for molecular mimicry with human proteinsImmune interference in multi-antigen formulationsSerotype-independent selective pressure
06

Interacting drugs

ASP1122

4 more in the full profile.

07

Biomarkers

Anti-PspA IgG titersAnti-PspC IgG titersOpsonophagocytic activity (OPA) titersC-reactive protein (CRP)Procalcitonin

Beyond the preview

Go deeper on Streptococcus pneumoniae conserved surface protein epitopes (Pneumococcal surface protein epitopes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae conserved surface protein epitopes (Pneumococcal surface protein epitopes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call